Bio-Rad Virotrol HBeAg Singapur - engleski - HSA (Health Sciences Authority)

bio-rad virotrol hbeag

bio-rad laboratories (singapore) pte ltd - microbiology - virotrol hbeag is intended for use as an unassayed reactive control with in vitro assay procedures for the qualitative determination of hepatitis b e antigen (hbeag). this product is designed for routine use to provide a means of estimating precision and monitoring test system performance. this product is not intended for use in conjunction with blood donor screening tests.

Bio-Rad Virotrol IV Singapur - engleski - HSA (Health Sciences Authority)

bio-rad virotrol iv

bio-rad laboratories (singapore) pte ltd - immunology - bio-rad virotrol iv is intended for use as an unassayed reactive control with in vitro enzyme immunoassay (eia) procedures for determination of antibodies to hepatitis b e antigen (anti-hbe). this product is designed for routine for routine use to provide a means of estimating precision and monitoring test system performance

GSK Consumer Healthcare (GMDT) Stiefel Biopsy Punch Singapur - engleski - HSA (Health Sciences Authority)

gsk consumer healthcare (gmdt) stiefel biopsy punch

glaxosmithkline pte ltd - general hospital - biopsy punch is intended for the successful removal of skin tissue for histological analysis or for the therapeutic removal of some forms of lesions where they can be contained within the lumen of the punch.

Solicare ODT solifenacin succinate 10 mg orodispersible tablets blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

solicare odt solifenacin succinate 10 mg orodispersible tablets blister pack

arrotex pharmaceuticals pty ltd - solifenacin succinate, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: lactose monohydrate; sucralose; polacrilin potassium; sodium stearylfumarate; croscarmellose sodium; mannitol; hypromellose; flavour - solicare odt is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Solicare ODT solifenacin succinate 5 mg orodispersible tablets blister pack Australija - engleski - Department of Health (Therapeutic Goods Administration)

solicare odt solifenacin succinate 5 mg orodispersible tablets blister pack

arrow pharma pty ltd - solifenacin succinate, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: hypromellose; sucralose; croscarmellose sodium; polacrilin potassium; lactose monohydrate; sodium stearylfumarate; mannitol; flavour - solicare odt is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Sitagliptin/Metformin P-Care 50 mg/850 mg film-coated tablets Malta - engleski - Medicines Authority

sitagliptin/metformin p-care 50 mg/850 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - metformin hydrochloride 850 mg sitagliptin 50 mg - drugs used in diabetes

Sitagliptin/Metformin P-Care 50 mg/1000 mg film-coated tablets Malta - engleski - Medicines Authority

sitagliptin/metformin p-care 50 mg/1000 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - metformin hydrochloride 1000 mg sitagliptin 50 mg - drugs used in diabetes

Atorvastatin P-Care 10 mg film-coated tablets Malta - engleski - Medicines Authority

atorvastatin p-care 10 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - atorvastatin 10 mg - lipid modifying agents

Atorvastatin P-Care 20 mg film-coated tablets Malta - engleski - Medicines Authority

atorvastatin p-care 20 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - atorvastatin 20 mg - lipid modifying agents

Atorvastatin P-Care 30 mg film-coated tablets Malta - engleski - Medicines Authority

atorvastatin p-care 30 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - atorvastatin 30 mg - lipid modifying agents